SCHEMBL3561653

SCHEMBL3561653

O=C(O)NCc1ccccc1Cl

nearest known ligand 0.75

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.75
RAB9A P51151 1/20 0.75
KMT2A Q03164 4/20 0.63
MEN1 O00255 3/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
L3MBTL1 Q9Y468 2/20 0.61
ALDH1A1 P00352 1/20 0.60
HTT P42858 1/20 0.58
CASR P41180 1/20 0.58
POLB P06746 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30858769 0.86 NPC1 (1.00) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL9156343 0.85 CYP1A2 (0.55) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL29935885 0.85 CYP1A2 (0.55) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL2912570 0.83 SMN1; SMN2 (0.82) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL3126847 0.83 P2RX7 (0.56) NPC1RAB9A
Hydrochloric Acid SCHEMBL11157053 0.83 CYP1A2 (0.53) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL23805061 0.82 NPC1 (0.72) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL11589808 0.82 NPC1 (0.72) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL625881 0.82 NPC1 (0.72) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1433979 0.82 NPC1 (0.72) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166587-B2 Carbamic acid alkyl ester derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-23 US claimed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 US claimed
EP-1673347-B1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS HOFFMANN LA ROCHE (CH) 2015-08-19 EP disclosed
US-7671072-B2 Aminopyrazole derivatives as GSK-3 inhibitors PFIZER INC. (US) 2010-03-02 US disclosed
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors BENBOW JOHN W 2007-11-29 US disclosed
US-7253177-B2 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2007-08-07 US disclosed
US-7166587-B2 Carbamic acid alkyl ester derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-23 US disclosed
EP-1673347-A1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS F. Hoffman-la Roche AG (CH) 2006-06-28 EP disclosed
WO-2006046949-A1 SYNTHESIS AND ANTIMALARIAL ACTIVITY OF PYRROLO[3,2-f]QUINAZOLINE-1,3- DIAMINE DERIVATIVES WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) (US) 2006-05-04 WO disclosed
US-20060094736-A1 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives ARMY, UNITED STATES 2006-05-04 US disclosed
WO-2005040126-A1 SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USEFUL AS GAMMA-SECRETASE INHIBITORS F. HOFFMAN-LA ROCHE AG (CH) 2005-05-06 WO disclosed
US-20050075327-A1 Carbamic acid alkyl ester derivatives HOFFMAN-LA ROCHE INC. 2005-04-07 US disclosed
US-4319018-A IN ACID CATALYST MITSUI TOATSU CHEMICALS, INC. (JP) 1982-03-09 US disclosed
EP-0031385-A1 PROCESS FOR PREPARING POLYMETHYLENEPOLYPHENYL POLYCARBAMATE MITSUI TOATSU CHEMICALS, Inc. (JP) 1981-07-08 EP disclosed
US-4190650-A Phosphonyl vinyl phosphorus compounds as pesticides BASF AKTIENGESELLSCHAFT (DE) 1980-02-26 US disclosed
US-4035488-A Insecticidal and acaricidal substituted phenyl thiophosphoric acid esters CIBA-GEIGY CORPORATION (US) 1977-07-12 US disclosed
US-3948940-A Pesticidal phthalimido phosphorous ester compounds CIBA-GEIGY CORPORATION (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075327-A1 Carbamic acid alkyl ester derivatives BCHE, CHRM1, ADCY7 NPC1 370/4885RAB9A 83/4885KMT2A 2212/4885
US-20060094736-A1 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives CPS1, PADI1, ALDH18A1 NPC1 3731/4885RAB9A 2346/4885KMT2A 328/4885
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors GSK3B, GSK3A, GSKIP NPC1 2332/4885RAB9A 3678/4885KMT2A 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.